Aandeel CEMI CHEMBIO DIAGNOSTICS, INC.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren
Inactief instrument

Andere talen Chembio Diagnostics, Inc.

Aandelen

CEMI

US1635722093

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Chembio Diagnostics, Inc. acquired FastPack® diagnostics business from Qualigen Therapeutics, Inc. for $5.8 million.
CHEMBIO DIAGNOSTICS, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
Biosynex Completes Acquisition of Chembio Diagnostics, Inc.
Chembio Diagnostics, Inc.(NasdaqCM:CEMI) dropped from NASDAQ Composite Index
Biosynex SA completed the acquisition of Chembio Diagnostics, Inc. from Perceptive Advisors LLC and others.
Chembio Stockholders Urged to Tender Shares Before 6:00 P.M., New York City Time, on April 26, 2023
Chembio Diagnostics Tender Offer Expiration Extended by Biosynex
Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.
Chembio Stockholders Reminded to Tender Shares Before 6:00 P.M., New York City Time, on April 12, 2023
CHEMBIO DIAGNOSTICS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
Chembio’s CEO Letter to Stockholders
CHEMBIO DIAGNOSTICS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
Chembio Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Chembio Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Biosynex : OPA prolongée sur Chembio Diagnostics
Biosynex Unit Extends Expiration Time of Tender Offer for Chembio Diagnostics Shares; Stock Rises
Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.
Chembio Diagnostics, Inc. Auditor Raises 'Going Concern' Doubt
CHEMBIO DIAGNOSTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
Chembio Stockholders Reminded to Tender Shares Before 6:00 PM New York City Time, on March 28, 2023
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers CEMI
  4. Nieuws Chembio Diagnostics, Inc.
  5. Andere talen